Gene · 4065
Papers1,798
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 1,798
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets. | Nat Cancer | 2020 | 35121932 | PubTator, text mining | PubMed |
| Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery. | Innovation (Camb) | 2020 | 34557710 | PubTator, text mining | PubMed |
| Multiscale Modeling of Germinal Center Recapitulates the Temporal Transition From Memory B Cells to Plasma Cells Differentiation as Regulated by Antigen Affinity-Based Tfh Cell Help. | Front Immunol | 2020 | 33613551 | PubTator, text mining | PubMed |
| Dendritic Cell Vaccines in Ovarian Cancer. | Front Immunol | 2020 | 33584699 | PubTator, text mining | PubMed |
| Proteus mirabilis Targets Atherosclerosis Plaques in Human Coronary Arteries via DC-SIGN (CD209). | Front Immunol | 2020 | 33488579 | PubTator, text mining | PubMed |
| Pathology of thymoma-where are we today? | J Thorac Dis | 2020 | 33447445 | PubTator, text mining | PubMed |
| Vaccine-Induced CD8+ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation. | Front Immunol | 2020 | 33424857 | PubTator, text mining | PubMed |
| Role of the α7 Nicotinic Acetylcholine Receptor in the Pathophysiology of Atherosclerosis. | Front Physiol | 2020 | 33424644 | PubTator, text mining | PubMed |
| Thymic Squamous Cell Carcinoma: A Population-Based Surveillance, Epidemiology, and End Result Analysis. | Front Oncol | 2020 | 33415074 | PubTator, text mining | PubMed |
| Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells. | Front Immunol | 2020 | 33335526 | PubTator, text mining | PubMed |
| Maturation of Monocyte-Derived DCs Leads to Increased Cellular Stiffness, Higher Membrane Fluidity, and Changed Lipid Composition. | Front Immunol | 2020 | 33329576 | PubTator, text mining | PubMed |
| Immunotherapy Advances for Epithelial Ovarian Cancer. | Cancers (Basel) | 2020 | 33322601 | PubTator, text mining | PubMed |
| Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs. | Clin Transl Immunology | 2020 | 33312564 | PubTator, text mining | PubMed |
| Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds. | Nat Commun | 2020 | 33311516 | PubTator, text mining | PubMed |
| Quality of CD8+ T cell immunity evoked in lymph nodes is compartmentalized by route of antigen transport and functional in tumor context. | Sci Adv | 2020 | 33310857 | PubTator, text mining | PubMed |
Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells. | Front Immunol | 2020 | 33281829 | PubTator, text mining | PubMed |
| U-DCS: characterization of the first permanent human dendritic sarcoma cell line. | Sci Rep | 2020 | 33277516 | PubTator, text mining | PubMed |
| Nanoparticle System Based on Amino-Dextran as a Drug Delivery Vehicle: Immune-Stimulatory CpG-Oligonucleotide Loading and Delivery. | Pharmaceutics | 2020 | 33260874 | PubTator, text mining | PubMed |
| DC-Based Vaccines for Cancer Immunotherapy. | Vaccines (Basel) | 2020 | 33255895 | PubTator, text mining | PubMed |
| TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice. | PLoS Pathog | 2020 | 33253297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4065/papers?page=27